immunotherapy

The findings offer potential for future research to improve the immune system’s response against cancers.

Scientists target scar tissue formation in a new heart failure treatment approach.

The treatment also showed a reduction in long-term side effects.

NIH researchers achieve tumor shrinkage with new immunotherapy using engineered cells.

The therapy was granted accelerated approval for its use in treating patients with metastatic and unremovable melanoma.

Mutated mitochondrial DNA is common among cancer patients, and luckily, it may provide a way to bolster treatment.